ASPH Regulates Osteogenic Differentiation and Cellular Senescence of BMSCs

Hui Peng,Qi Guo,Ye Xiao,Tian Su,Tie-Jian Jiang,Li-Juan Guo,Min Wang
DOI: https://doi.org/10.3389/fcell.2020.00872
IF: 5.5
2020-09-03
Frontiers in Cell and Developmental Biology
Abstract:Osteogenesis and senescence of BMSCs play great roles in age-related bone loss. However, the causes of these dysfunctions remain unclear. In this study, we identified a differentially expressed <i>ASPH</i> gene in middle-aged and elderly aged groups which were obtained from GSE35955. Subsequent analysis in various databases, such as TCGA, GTEx, and CCLE, revealed that <i>ASPH</i> had positive correlations with several osteogenic markers. The depletion of mouse <i>Asph</i> suppressed the capacity of osteogenic differentiation in bone marrow mesenchymal stem cells (BMSCs). Notably, the expression of <i>ASPH in vitro</i> decreased during aging and senescence. The deficiency of <i>Asph</i> accelerated cellular senescence in BMSCs. Conversely, the overexpression of <i>Asph</i> enhanced the capacity of osteogenic differentiation and inhibited cellular senescence. Mechanistically, <i>ASPH</i> regulated Wnt signaling mediated by Gsk3β. Taken together, our data established that <i>ASPH</i> was potentially involved in the pathogenesis of age-related bone loss through regulating cellular senescence and osteogenic differentiation, which provides some new insights to treat age-related bone loss.
cell biology,developmental biology
What problem does this paper attempt to address?